Fulgent Genetics Inc.

27.47-0.1100-0.40%Vol 121.43K1Y Perf -23.54%
Dec 1st, 2023 16:00 DELAYED
BID26.48 ASK28.48
Open27.45 Previous Close27.58
Pre-Market- After-Market27.15
 - -  -0.32 -1.16%
Target Price
42.50 
Analyst Rating
Moderate Buy 2.50
Potential %
54.71 
Finscreener Ranking
★★★★★     66.75
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★★     73.94
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     84.43
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
20.86 
Earnings Rating
Neutral
Market Cap814.02M 
Earnings Date
3rd Nov 2023
Alpha0.04 Standard Deviation0.25
Beta1.57 

Today's Price Range

27.0627.87

52W Range

23.0944.09

5 Year PE Ratio Range

-670.0021.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-1.25%
1 Month
16.13%
3 Months
-15.45%
6 Months
-32.24%
1 Year
-23.54%
3 Years
-39.85%
5 Years
676.90%
10 Years
-

TickerPriceChg.Chg.%
FLGT27.47-0.1100-0.40
AAPL191.241.29000.68
GOOG133.32-0.6000-0.45
MSFT374.51-4.4000-1.16
XOM102.990.25000.24
WFC45.020.43000.96
JNJ158.383.72002.41
FB196.640.99000.51
GE122.500.70000.57
JPM156.840.76000.49
Financial StrengthValueIndustryS&P 500US Markets
6.60
8.20
0.01
0.02
12.21K
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
67.70
45.90
49.20
18.50
30.11
RevenueValueIndustryS&P 500US Markets
551.26M
18.24
257.33
134.94
Earnings HistoryEstimateReportedSurprise %
Q03 2023-0.61-0.4329.51
Q02 2023-0.59-0.3344.07
Q01 2023-0.68-0.4730.88
Q04 2022-0.78-0.718.97
Q03 2022-0.020.11650.00
Q02 20220.590.590.00
Q01 20224.324.9314.12
Q04 20212.663.3425.56
Earnings Per EndEstimateRevision %Trend
12/2023 QR-0.631.56Positive
12/2023 FY-2.090.48Positive
3/2024 QR-0.49-2.08Negative
12/2024 FY-1.92-1.05Negative
Next Report Date-
Estimated EPS Next Report-0.61
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume121.43K
Shares Outstanding29.63K
Shares Float20.22M
Trades Count3.80K
Dollar Volume3.33M
Avg. Volume185.27K
Avg. Weekly Volume143.31K
Avg. Monthly Volume195.24K
Avg. Quarterly Volume217.26K

Fulgent Genetics Inc. (NASDAQ: FLGT) stock closed at 27.58 per share at the end of the most recent trading day (a -0.18% change compared to the prior day closing price) with a volume of 158.33K shares and market capitalization of 814.02M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 139 people. Fulgent Genetics Inc. CEO is Ming Hsieh.

The one-year performance of Fulgent Genetics Inc. stock is -23.54%, while year-to-date (YTD) performance is -7.39%. FLGT stock has a five-year performance of 676.9%. Its 52-week range is between 23.09 and 44.09, which gives FLGT stock a 52-week price range ratio of 20.86%

Fulgent Genetics Inc. currently has a PE ratio of 3.40, a price-to-book (PB) ratio of 0.70, a price-to-sale (PS) ratio of 1.66, a price to cashflow ratio of 3.10, a PEG ratio of -, a ROA of 22.39%, a ROC of 22.95% and a ROE of 25.20%. The company’s profit margin is 30.11%, its EBITDA margin is 49.20%, and its revenue ttm is $551.26 Million , which makes it $18.24 revenue per share.

Of the last four earnings reports from Fulgent Genetics Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.61 for the next earnings report. Fulgent Genetics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Fulgent Genetics Inc. is Moderate Buy (2.5), with a target price of $42.5, which is +54.71% compared to the current price. The earnings rating for Fulgent Genetics Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fulgent Genetics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Fulgent Genetics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 18.20, ATR14 : 0.80, CCI20 : 68.88, Chaikin Money Flow : -0.08, MACD : 0.43, Money Flow Index : 36.34, ROC : 5.31, RSI : 58.03, STOCH (14,3) : 76.34, STOCH RSI : 0.03, UO : 42.81, Williams %R : -23.66), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fulgent Genetics Inc. in the last 12-months were: Gao Hanlin (Sold 1 000 shares of value $40 296 ), Hanlin Gao (Sold 2 386 shares of value $85 232 ), Kim Paul (Sold 15 767 shares of value $530 159 ), Paul Kim (Sold 653 shares of value $23 070 ), Xie Jian (Sold 7 169 shares of value $239 759 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.50
Moderate Buy
2.50
Moderate Buy
2.50

Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to a disease and enhanced disease treatment and prognosis.

CEO: Ming Hsieh

Telephone: +1 626 350-0537

Address: 4978 Santa Anita Avenue, Temple City 91780, CA, US

Number of employees: 139

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

54%46%

 

News

Stocktwits